Peer Review of Research Assures Standards of Quality
2008 Publications
| Defective remodeling and maturation of lymphatic vasculature in Angiooietin-2 deficient mice Dellinger M, Hunter R, Bernas M Gale N, Yancopoulous G, Erickson R, Witte M. Developmental Biology. 19(2):309-20 |
| Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies Hoffman HM, Throne ML, Amar NJ, Sebai M, Kivitz AJ, Kvanaugh A, Weinstein SP, Belomestnov P, Yancopoulous GD, Stahl N, Mellis SJ Arthritis Rheum. 58(8):1443-52 |
| Expression of BMP-7 and USAG-1, a BMP antagonist, in kidney development and injury) Tanaka M, Endo S., Okuda T., Economides AN., Valenzuela DM, Murphy AJ, Robertson E, Sakurai T, Fukatsu A, Yancopoulos GD, Kita T, Yanagita M. Kidney International. 73(2):181-91 |
| Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation Nair MG, Guikd KJ., Du Y.,Yancopoulos, GD., Valenzuela DM, Murphy A., Stevens S, Karow M., Artis D. Journal of Immunology. 181(7):4709-15 |
| The transccription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis Weigmann B, Lehr HA, Yancopoulos G, Valenzuela, D, Murh A, Stevens S, Schmidt J, Galle PR, Rose-John, S., Neurath MF. Journal of Experimental Medicine. 205(9):2099-110 |
| Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives Stych B, Dobrovolny D Current Medical Research and Opinion. 24(6):1577-82 |
| CD133 expression is not restricted to stem cells, and both CD133 and CD133 metastatic colon cancer cells initiate tumors. Shmelkov SV, Butler JM, Hooper AT, Hormigo A, Kushner J, Milde T, St Clair R, Baljevic M, White I, Jin DK, Chadburn A, Murphy AJ, Valenzuela DM, Gale NW, Thurston G, Yancopoulos GD, D'Angelica M, Kemeny N, Lyden D, Rafii S. Journal of Clinical Investigation. 118(6):2111-2120 |
| The Role of Vascular Endothelial Growth Factor and Estradiol in the Regulation of Endometrial Angiogenesis and Cell Proliferation in the Marmoset. Fraser HM, Fraser HM, Wilson H, Silvestri A, Morris KD, Wiegand SJ. Endocrinology. 149(9):4413-20 |
| The CAMplexities of central ghrelin. Sleeman MW,, Latres E Cell Metabolism. 7(5):361-2 |
| The mutation ROR2W749X, linked to human BDB, is a recessive mutation in the mouse, causing brachydactyly, mediating patterning of joints and modeling recessive Robinow syndrome. Raz R, Stricker S, Gazzerro E, Clor JL, Witte F, Nistala H, Zabski S, Pereira RC, Stadmeyer L, Wang X, Gowen L, Sleeman MW, Yancopoulos GD, Canalis E, Mundlos S, Valenzuela DM, Economides AN. Development (Cambridge, England). 135(9):1713-23 |
| Regeneron focuses on age-related macular degeneration. Wolfson W., Chemistry and Biology. 15(4):303-4 |
| Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell responses during viral infections. Towne CF, York IA, Neijssen J, Karow ML, Murphy AJ, Valenzuela DM, Yancopoulos GD, Neefjes JJ, Rock KL. Journal of Immunology. 180(3):1704-12 |
| Angiopoietin-1 therapy enhances fibrosis and inflammation following folic acid-induced acute renal injury. Long DA, Price KL, Ioffe E, Gannon CM, Gnudi L, White KE, Yancopoulos GD, Rudge JS, Woolf AS. Kidney International. 74(3):300-9 |
| Impact of vessel maturation on antiangiogenic therapy in ovarian cancer. Lu C, Thaker PH, Lin YG, Spannuth W, Landen CN, Merritt WM, Jennings NB, Langley RR, Gershenson DM, Yancopoulos GD, Ellis LM, Jaffe RB, Coleman RL, Sood AK American Journal of Obstetrics and Gynecology. 189(4):477.e1-9; discussion 477.e9-10. |
| Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Kadenhe-Chiweshe A, Papa J, McCrudden KW, Frischer J, Bae JO, Huang J, Fisher J, Lefkowitch JH, Feirt N, Rudge J, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ Molecular Cancer Research (MCR). 6(1):9-Jan |
| Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Ramalingam TR, Pesce JT, Sheikh F, Cheever AW, Mentink-Kane MM, Wilson MS, Stevens S, Valenzuela DM, Murphy AJ, Yancopoulos GD, Urban JF Jr, Donnelly RP, Wynn TA. Nature Immunology. 9(1):25-33 |